However, SCG2 expression was significantly lower in colon adenocarcinoma (COAD), kidney chromophobe (KICH), prostate adenocarcinoma (PRAD), rectum adenocarcinoma (READ), stomach adenocarcinoma (STAD), uterine corpus endometrial carcinoma (UCEC) compared with adjacent normal tissues (Figure 1A). This evidence concerns the gene SCG2 and gastric adenocarcinoma.